October 23, 2017 / 1:13 PM / a month ago

BRIEF-Curetis initiates FDA study for Unyvero IJI Cartridge

Oct 23 (Reuters) - CURETIS NV:

* CURETIS INITIATES U.S. FDA STUDY FOR UNYVERO INVASIVE JOINT INFECTIONS CARTRIDGE

* ‍PROSPECTIVE CLINICAL TRIAL EXPECTED TO START IN 2018​

* ‍CARTRIDGE WILL BE NEWLY DEVELOPED U.S. VERSION BASED ON UNYVERO ITI CARTRIDGE

* ‍UNYVERO IJI CARTRIDGE IS SECOND UNYVERO APPLICATION TO UNDERGO A U.S. FDA STUDY​

* ‍CLEARANCE DECISION BY FDA FOR UNYVERO LRT INFECTIONS APPLICATION EXPECTED BY END OF 2017​

* ‍FIRST PATIENT SAMPLES WERE COLLECTED IN EARLY OCTOBER​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below